Lifelong

Lifelong is a SAMHSA-registered addiction-treatment facility located at Berkeley, CA. The specific care levels offered by Lifelong should be confirmed directly with the admissions team. Patient-level evaluation of this facility should distinguish three considerations: state licensure status, voluntary accreditation (CARF or Joint Commission), and clinical-framework alignment with current ASAM Criteria — each of which is independently verifiable.

Care levels at Lifelong

Level-of-care documentation: Care-level specifics for Lifelong are not well-documented in the public SAMHSA record; a direct conversation with the admissions team is the reliable way to confirm what the facility actually provides. Under MHPAEA 2024 medical-necessity criteria disclosure, plan-specific criteria for each of these levels must be available to patients upon request. Mismatch between documented clinical need and offered level of care is a common source of authorization denial.

Insurance and payment

Payment and insurance specifics for Lifelong are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. Benefit verification should be obtained in writing prior to admission and should document: network contract status for the specific insurance product, prior authorization requirements and approved day-count, applicable cost-sharing structure, and out-of-network secondary coverage (where applicable). Proceeding on verbal VOB creates material risk of post-admission benefit dispute.

Before you call

Operational admission checklist for Lifelong: (a) clinical assessment with documented ASAM 4e level-of-care recommendation; (b) insurance benefits verification in writing; (c) MAT policy documentation; (d) accreditation and licensure verification; (e) confirmed prior authorization for specific level of care. Each should be obtained in written form prior to admission. If the clinical situation involves opioid use disorder, confirm explicitly whether Lifelong offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.